Here's Why Maximus Stock Is a Great Pick for Your Portfolio

17.09.25 19:52 Uhr

Werte in diesem Artikel
Aktien

74,00 EUR 0,50 EUR 0,68%

Maximus MMS, a leading global provider of government health and human-services programs, has performed well over the year-to-date period and has the potential to sustain momentum in the near term. If you have not yet taken advantage of the share price appreciation, you should consider adding the stock to your portfolio now.  What Makes MMS an Attractive Pick?An Outperformer: A glimpse at the company’s price trend shows that the stock has had an impressive run over the year-to-date period. Shares of MMS have rallied 17.5% in the same time period, outperforming the 5% decline of the Government Services industry it belongs to. Image Source: Zacks Investment ResearchSolid Rank: MMS sports a Zacks Rank #1 (Strong Buy).Positive Earnings Surprise History: MMS has an impressive earnings surprise history. The company outpaced the Zacks Consensus Estimate in three of the trailing four quarters and missed once, delivering an earnings surprise of 29.3%, on average. Strong Growth Prospects: The Zacks Consensus Estimate for Maximus’s 2025 revenues is pegged at $5.45 billion, reflecting 2.74% year-over-year growth. The consensus estimate for 2025 earnings is pegged at $7.41, hinting at a 21.28% year-over-year increase.Growth Factors: Maximus is enhancing its competitive edge with the achievement of CMMC Level 2 certification in August 2025. This demonstrates its ability to meet strict Department of Defense cybersecurity standards, safeguard sensitive defense data and accelerate program launches by bypassing lengthy Authorization to Operate delays. This milestone reinforces Maximus’ position as a trusted partner for defense and national security missions.MMS's current ratio (a measure of liquidity) at the end of the third quarter of fiscal 2025 was 2.27, higher than the industry’s 1.35. A current ratio of more than 1 indicates that the company should not have problems meeting its short-term obligations.Moreover, the company has a solid track record of dividend payments. During fiscal 2021, 2022, 2023 and 2024, Maximus paid cash dividends of $68.8 million, $68.7 million, $68 million and $72.9 million, respectively. These steady payouts indicate the company’s commitment to creating value for shareholders and highlight its confidence in the business.Other Stocks to ConsiderSome other top-ranked stocks to consider from the broader Zacks Business Services sector are Green Dot (GDOT) and AppLovin (APP) Green Dot sports a Zacks Rank of #1 at present. You can see the complete list of today’s Zacks #1 Rank stocks hereGDOT has an encouraging earnings surprise history, having outpaced the Zacks Consensus Estimate in three of the trailing four quarters and missing once. The average beat is 42.1%.AppLovin also sports a Zacks Rank of 1.APP has an encouraging earnings surprise history, topping the Zacks Consensus Estimate in each of the trailing four quarters. The average beat is 22.36%.Radical New Technology Could Hand Investors Huge GainsQuantum Computing is the next technological revolution, and it could be even more advanced than AI.While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power.Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.See Top Quantum Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Green Dot Corporation (GDOT): Free Stock Analysis Report Maximus, Inc. (MMS): Free Stock Analysis Report AppLovin Corporation (APP): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Maximus und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Maximus

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Maximus

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Maximus Inc.

Wer­bung

Analysen zu Maximus Inc.

DatumRatingAnalyst
08.05.2018Maximus OverweightFirst Analysis Securities
08.02.2018Maximus HoldMaxim Group
04.05.2017Maximus HoldMaxim Group
07.04.2017Maximus HoldCanaccord Adams
04.12.2015Maximus BuyStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst
08.05.2018Maximus OverweightFirst Analysis Securities
04.12.2015Maximus BuyStifel, Nicolaus & Co., Inc.
12.11.2015Maximus BuyMaxim Group
06.08.2015Maximus BuyMaxim Group
07.05.2015Maximus BuyMaxim Group
DatumRatingAnalyst
08.02.2018Maximus HoldMaxim Group
04.05.2017Maximus HoldMaxim Group
07.04.2017Maximus HoldCanaccord Adams
24.08.2006Update Maximus Inc.: HoldMatrix Research
15.07.2005Update Maximus Inc.: NeutralSun Trust Robinson Humphrey
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Maximus Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen